Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II)

Gynecol Oncol. 1992 Apr;45(1):13-9. doi: 10.1016/0090-8258(92)90484-z.
No abstract available

MeSH terms

  • Cell Transformation, Neoplastic / drug effects
  • Cell Transformation, Neoplastic / pathology
  • Cisplatin / standards
  • Cisplatin / therapeutic use*
  • Drug Synergism
  • Endometrial Neoplasms / drug therapy*
  • Endometrial Neoplasms / pathology
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • Quercetin / standards
  • Quercetin / therapeutic use*

Substances

  • Quercetin
  • Cisplatin